Menu Menu

ADAP    Adaptimmune Therapeutics Plc    1621227    
Income Statement
Revenue adap-20240930x10q 40,901,000
Net Income adap-20240930x10q -17,617,000
Profit Margin -43.07%

Balance Sheet
Current Assets 244,214,000
Assets 317,436,000
Current Liabilities 63,457,000
Liabilities 237,447,000
Equity 79,989,000
Shares Out 1,534,473,000

Cash Flow Statement
Operating Cash Flow -39,002,000
Investing Cash Flow -67,119,000

Market Analysis
Market Cap 268,532,657
Price 0.58
BVPS 0.05
PB 10.94
EPS -0.35
PS 1.64
FCF -106,121,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/06 2.82
Apr May Jun
5/15
Jul Aug Sep
8/12
Oct Nov Dec
11/06

Find a discrepancy? The most accurate way to find company fundamental data is to view ADAP documents filed with the SEC.


ADAP Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas